{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:27:47Z","timestamp":1793924867843,"version":"4.8.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1 TR001425"],"award-info":[{"award-number":["UL1 TR001425"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI073713"],"award-info":[{"award-number":["R01 AI073713"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI104709"],"award-info":[{"award-number":["R01 AI104709"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.vaccine.2026.129244","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T12:09:42Z","timestamp":1792498182000},"page":"129244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cross-protection and type-replacement over the 17\u00a0years after human papillomavirus vaccine introduction in young women"],"prefix":"10.1016","volume":"94","author":[{"given":"Jessica A.","family":"Kahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Ermel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aislinn","family":"DeSieghardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sem","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darron","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casey","family":"Dagnall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrit","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo L.","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10451","key":"10.1016\/j.vaccine.2026.129244_bb0005","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0140-6736(24)01097-3","article-title":"Causal attribution of human papillomavirus genotypes to invasive cervical cancer worldwide: a systematic analysis of the global literature","volume":"404","author":"Wei","year":"2024","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129244_bb0010","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ijc.30716","article-title":"Worldwide burden of cancer attributable to HPV by site, country and HPV type","volume":"141","author":"de Martel","year":"2017","journal-title":"Int. J. Cancer"},{"issue":"52","key":"10.1016\/j.vaccine.2026.129244_bb0015","doi-asserted-by":"crossref","first-page":"6844","DOI":"10.1016\/j.vaccine.2008.09.073","article-title":"HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine","volume":"26","author":"Joura","year":"2008","journal-title":"Vaccine"},{"issue":"9686","key":"10.1016\/j.vaccine.2026.129244_bb0020","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","article-title":"Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women","volume":"374","author":"Paavonen","year":"2009","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.vaccine.2026.129244_bb0025","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1405044","article-title":"A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women","volume":"372","author":"Joura","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.vaccine.2026.129244_bb0030","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/jnci\/djab080","article-title":"Real-world effectiveness of human papillomavirus vaccination against cervical Cancer","volume":"113","author":"Kjaer","year":"2021","journal-title":"J. Natl. Cancer Inst."},{"issue":"6","key":"10.1016\/j.vaccine.2026.129244_bb0035","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/jnci\/djad263","article-title":"Invasive cervical cancer incidence following bivalent human papillomavirus vaccination: a population-based observational study of age at immunization, dose, and deprivation","volume":"116","author":"Palmer","year":"2024","journal-title":"J. Natl. Cancer Inst."},{"issue":"12","key":"10.1016\/j.vaccine.2026.129244_bb0040","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1001\/jamapediatrics.2025.3568","article-title":"Population-level effectiveness and herd protection 17 years after HPV vaccine introduction","volume":"179","author":"DeSieghardt","year":"2025","journal-title":"JAMA Pediatr."},{"issue":"7","key":"10.1016\/j.vaccine.2026.129244_bb0045","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1086\/597307","article-title":"The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years","volume":"199","author":"Brown","year":"2009","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.vaccine.2026.129244_bb0050","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/infdis\/jiaa032","article-title":"Human papillomavirus genotype replacement: still too early to tell?","volume":"224","author":"Man","year":"2021","journal-title":"J. Infect. Dis."},{"issue":"11","key":"10.1016\/j.vaccine.2026.129244_bb0055","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/aje\/kwu265","article-title":"Invited commentary: multiple human papillomavirus infections and type replacement-anticipating the future after human papillomavirus vaccination","volume":"180","author":"Safaeian","year":"2014","journal-title":"Am. J. Epidemiol."},{"issue":"1623","key":"10.1016\/j.vaccine.2026.129244_bb0060","first-page":"20120150","article-title":"Vacated niches, competitive release and the community ecology of pathogen eradication","volume":"368","author":"Lloyd-Smith","year":"2013","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"key":"10.1016\/j.vaccine.2026.129244_bb0065","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jtbi.2013.12.028","article-title":"Revising ecological assumptions about human papillomavirus interactions and type replacement","volume":"350","author":"Murall","year":"2014","journal-title":"J. Theor. Biol."},{"issue":"1","key":"10.1016\/j.vaccine.2026.129244_bb0070","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.virol.2010.02.002","article-title":"Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments","volume":"401","author":"Bernard","year":"2010","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.vaccine.2026.129244_bb0075","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3201\/eid0503.990304","article-title":"Bacterial vaccines and serotype replacement: lessons from haemophilus influenzae and prospects for Streptococcus pneumoniae","volume":"5","author":"Lipsitch","year":"1999","journal-title":"Emerg. Infect. Dis."},{"issue":"3","key":"10.1016\/j.vaccine.2026.129244_bb0080","doi-asserted-by":"crossref","first-page":"e408","DOI":"10.1542\/peds.2004-2338","article-title":"Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004","volume":"116","author":"Huang","year":"2005","journal-title":"Pediatrics"},{"issue":"11","key":"10.1016\/j.vaccine.2026.129244_bb0085","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.chom.2023.10.001","article-title":"Ecological diversity profiles of non-vaccine-targeted HPVs after gender-based community vaccination efforts","volume":"31","author":"Pimenoff","year":"2023","journal-title":"Cell Host Microbe"},{"issue":"16","key":"10.1016\/j.vaccine.2026.129244_bb0090","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/j.vaccine.2020.11.076","article-title":"Systematic literature review of cross-protective effect of HPV vaccines based on data from randomized clinical trials and real-world evidence","volume":"39","author":"Brown","year":"2021","journal-title":"Vaccine"},{"issue":"45","key":"10.1016\/j.vaccine.2026.129244_bb0095","doi-asserted-by":"crossref","first-page":"6734","DOI":"10.1016\/j.vaccine.2023.10.002","article-title":"The impact of over ten years of HPV vaccination in England: surveillance of type-specific HPV in young sexually active females","volume":"41","author":"Checchi","year":"2023","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129244_bb0100","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/OLQ.0000000000000731","article-title":"Non-vaccine-type human papillomavirus prevalence after vaccine introduction: no evidence for type replacement but evidence for cross-protection","volume":"45","author":"Saccucci","year":"2018","journal-title":"Sex. Transm. Dis."},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2026.129244_bb0105","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1080\/21645515.2018.1564438","article-title":"Evidence for cross-protection but not type-replacement over the 11 years after human papillomavirus vaccine introduction","volume":"15","author":"Covert","year":"2019","journal-title":"Hum. Vaccin. Immunother."},{"issue":"12","key":"10.1016\/j.vaccine.2026.129244_bb0110","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1002\/ijc.33169","article-title":"Long-term follow-up of human papillomavirus type replacement among young pregnant Finnish females before and after a community-randomised HPV vaccination trial with moderate coverage","volume":"147","author":"Gray","year":"2020","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129244_bb0115","doi-asserted-by":"crossref","first-page":"e165","DOI":"10.1093\/infdis\/jiae455","article-title":"Changes in genital human papillomavirus (HPV) prevalence during 12 years of girls-only bivalent HPV vaccination: results from a biennial repeated cross-sectional study","volume":"231","author":"Kusters","year":"2025","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.vaccine.2026.129244_bb0120","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1542\/peds.2011-3587","article-title":"Vaccine-type human papillomavirus and evidence of herd protection after vaccine introduction","volume":"130","author":"Kahn","year":"2012","journal-title":"Pediatrics"},{"issue":"10","key":"10.1016\/j.vaccine.2026.129244_bb0125","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/cid\/ciw533","article-title":"Substantial decline in vaccine-type human papillomavirus (HPV) among vaccinated young women during the first 8 years after HPV vaccine introduction in a community","volume":"63","author":"Kahn","year":"2016","journal-title":"Clin. Infect. Dis."},{"issue":"5 Pt 1","key":"10.1016\/j.vaccine.2026.129244_bb0130","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1097\/01.AOG.0000124569.61462.8d","article-title":"Comparison of adolescent and young adult self-collected and clinician-collected samples for human papillomavirus","volume":"103","author":"Kahn","year":"2004","journal-title":"Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.vaccine.2026.129244_bb0135","doi-asserted-by":"crossref","first-page":"e906","DOI":"10.1093\/infdis\/jiaf369","article-title":"Validation of TypeSeq2, a next-generation-based sequencing assay for the detection of 46 human papillomavirus genotypes, at the US National Cancer Institute and Costa Rica laboratories","volume":"232","author":"Sierra","year":"2025","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2026.129244_bb0140","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1128\/JCM.38.1.357-361.2000","article-title":"Improved amplification of genital human papillomaviruses","volume":"38","author":"Gravitt","year":"2000","journal-title":"J. Clin. Microbiol."},{"issue":"4","key":"10.1016\/j.vaccine.2026.129244_bb0145","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1177\/1557988316645155","article-title":"Factors associated with HPV vaccine initiation, vaccine completion, and accuracy of self-reported vaccination status among 13- to 26-year-old men","volume":"12","author":"Thomas","year":"2018","journal-title":"Am. J. Mens Health"},{"issue":"12","key":"10.1016\/j.vaccine.2026.129244_bb0150","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/aje\/kwj149","article-title":"Variable selection for propensity score models","volume":"163","author":"Brookhart","year":"2006","journal-title":"Am. J. Epidemiol."},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2026.129244_bb0155","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.virol.2013.04.023","article-title":"Cross-roads in the classification of papillomaviruses","volume":"445","author":"de Villiers","year":"2013","journal-title":"Virology"},{"issue":"9961","key":"10.1016\/j.vaccine.2026.129244_bb0160","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/S0140-6736(14)60920-X","article-title":"Efficacy, safety, and immunogenicity of the human papillomavirus 16\/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study","volume":"384","author":"Skinner","year":"2014","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.vaccine.2026.129244_bb0165","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S1470-2045(15)00047-9","article-title":"Efficacy of fewer than three doses of an HPV-16\/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica vaccine and PATRICIA trials","volume":"16","author":"Kreimer","year":"2015","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.vaccine.2026.129244_bb0170","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3201\/eid2201.150736","article-title":"Human papillomavirus prevalence and herd immunity after introduction of vaccination program, Scotland, 2009\u20132013","volume":"22","author":"Cameron","year":"2016","journal-title":"Emerg. Infect. Dis."},{"issue":"11","key":"10.1016\/j.vaccine.2026.129244_bb0175","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/bjc.2016.97","article-title":"Impact of partial bivalent HPV vaccination on vaccine-type infection: a population-based analysis","volume":"114","author":"Cuschieri","year":"2016","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.vaccine.2026.129244_bb0180","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/infdis\/jiy249","article-title":"The impact of the national HPV vaccination program in England using the bivalent HPV vaccine: surveillance of type-specific HPV in young females, 2010-2016","volume":"218","author":"Mesher","year":"2018","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.vaccine.2026.129244_bb0185","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1473-3099(14)71073-4","article-title":"Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis","volume":"15","author":"Drolet","year":"2015","journal-title":"Lancet Infect. Dis."},{"issue":"12","key":"10.1016\/j.vaccine.2026.129244_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166329","article-title":"Epidemiologic evaluation of human papillomavirus type competition and the potential for type replacement post-vaccination","volume":"11","author":"Tota","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129244_bb0195","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1158\/1055-9965.EPI-14-0566","article-title":"Evaluation of human papillomavirus type replacement postvaccination must account for diagnostic artifacts: masking of HPV52 by HPV16 in anogenital specimens","volume":"24","author":"Tota","year":"2015","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"24","key":"10.1016\/j.vaccine.2026.129244_bb0200","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1056\/NEJMoa2506765","article-title":"Noninferiority of one HPV vaccine dose to two doses","volume":"393","author":"Kreimer","year":"2025","journal-title":"N. Engl. J. Med."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26010534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26010534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:55:53Z","timestamp":1793922953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26010534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":40,"alternative-id":["S0264410X26010534"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129244","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cross-protection and type-replacement over the 17\u00a0years after human papillomavirus vaccine introduction in young women","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129244","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"129244"}}